|
⚲
|
| Keyboard |
| Heartbeam Inc | |
|---|---|
| Ticker | BEAT |
| CIK # | 0001779372 |
| CUSIP | 090672106 |
| Sector | Life Sciences - Surgical & Medical Instruments & Apparatus |
| Address | 2118 Walsh Ave, Suite 210, Santa Clara, CA 95050 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Heartbeam Inc | 2019-08-16 | 0.2 M | Exemption: 506(c) · Minimum: $5,000 · Remaining: $1,877,000 · Duration: One year or less · Commission: $20,770 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001779372] | 10-K | |
| [0001779372] | 10-Q | |
| [0001779372] | 3 | |
| [0001779372] | 4 | |
| [0001779372] | 8-K | |
| [0001779372] | D | |
| [0001779372] | SC 13D | |
| [0001779372] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Strome Mark E | Heartbeam Inc | [2023-10-25] | 819412.0 |
| Public Ventures LLC | Heartbeam Inc | [2023-08-28] | 0.41 |
| Schwartzberg Andrew | Heartbeam Inc | [2023-06-02] | 7.33 |
| Sabby Management LLC | Heartbeam Inc | [2021-11-17] | 5.16 |
| Ionic Ventures LLC | Heartbeam Inc | [2021-11-16] | 0.99 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
JAFF Michael R
Common Stock
|
2026-02-09 | Grant | 20,689 | $0.00 | |
|
Nelson Kenneth Warwick III
Common Stock
|
2026-02-09 | Grant | 17,241 | $0.00 | |
|
Ortigas-Wedekind Marga
Common Stock(right to buy) · derivative
|
2026-02-09 | Grant | 44,827 | $0.00 | |
|
Ferrari Richard
Common Stock
|
2026-02-09 | Grant | 50,000 | $0.00 | |
|
Strome Mark E
Common Stock (right to buy) · derivative
|
2026-02-09 | Grant | 41,380 | $0.00 | |
|
Vajdic Branislav
Common Stock (right to buy) · derivative
|
2026-02-09 | Grant | 61,932 | $0.00 | |
|
Cruickshank Tim
Common Stock (right to buy) · derivative
|
2026-02-09 | Grant | 53,104 | $0.00 | |
|
Elfrink Willem
Common Stock (right to buy) · derivative
|
2026-02-09 | Grant | 51,724 | $0.00 | |
|
de Urioste George
Common Stock (right to buy) · derivative
|
2026-02-09 | Grant | 51,724 | $0.00 | |
|
ENO Robert Paul
Common Stock (right to buy) · derivative
|
2026-02-09 | Grant | 55,172 | $0.00 | |
|
de Urioste George
Common Stock
|
2025-12-18 | Sell | 33,185 | $2.83 | 93,914 |
|
de Urioste George
Common Stock
|
2025-12-17 | Sell | 23,961 | $3.68 | 88,176 |
|
Strome Mark E
Common Stock
|
2025-12-17 | Sell | 250,000 | $3.58 | 895,000 |
|
Cruickshank Tim
Common Stock (right to buy) · derivative
|
2025-04-07 | Grant | 150,000 | $0.00 | |
|
ENO Robert Paul
Stock option (right to buy) · derivative
|
2025-04-07 | Grant | 320,000 | $0.00 | |
|
Persen Kenneth Harry
Stock option (right to buy) · derivative
|
2025-04-07 | Grant | 20,000 | $0.00 | |
|
Vajdic Branislav
Stock option (right to buy) · derivative
|
2025-04-07 | Grant | 180,000 | $0.00 | |
|
Ferrari Richard
Common Stock
|
2025-02-14 | Buy | 29,412 | $1.70 | 50,000 |
|
Cruickshank Tim
Common Stock
|
2025-02-14 | Buy | 17,647 | $1.70 | 30,000 |
|
Cruickshank Tim
Common Stock (right to buy) · derivative
|
2024-09-25 | Grant | 400,000 | $2.28 | 912,000 |
| showing 20 of 123 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 38 | 5,145,200 |
| 2025-12-31 | 41 | 4,563,602 |
| 2025-09-30 | 38 | 3,346,747 |
| 2025-06-30 | 41 | 3,596,382 |
| 2025-03-31 | 36 | 3,039,032 |
| 2024-12-31 | 34 | 2,648,067 |
| 2024-09-30 | 33 | 2,611,687 |
| 2024-06-30 | 31 | 2,267,917 |
| 2024-03-31 | 29 | 2,154,349 |
| 2023-12-31 | 34 | 2,144,444 |
| 2023-09-30 | 29 | 1,704,011 |
| 2023-06-30 | 29 | 1,617,369 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Davidson Kahn Capital Management LLC | [2026-06-30] | SOLE | 0 | 17,333 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 6,000 | Prev | Page 1 | Next |